Back
MAXIMUS, Inc. 10K Form
Sell
40
MMS
MAXIMUS, Inc.
Last Price:
$74.70
Seasonality Move:
2.19%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | MMS/MAXIMUS, Inc. Quarterly |
| 2024-02-08 | 10Q | MMS/MAXIMUS, Inc. Quarterly |
| 2023-08-03 | 10Q | MMS/MAXIMUS, Inc. Quarterly |
| 2023-05-04 | 10Q | MMS/MAXIMUS, Inc. Quarterly |
| 2023-02-09 | 10Q | MMS/MAXIMUS, Inc. Quarterly |
| 2022-08-04 | 10Q | MMS/MAXIMUS, Inc. Quarterly |
Receive MMS News And Ratings
See the #1 stock for the next 7 days that we like better than MMS
MMS Financial Statistics
Sales & Book Value
| Annual Sales: | $5.4B |
|---|---|
| Cash Flow: | $-250.7M |
| Price / Cash Flow: | 19.34 |
| Annual Sales: | $31.53 |
| Price / Book: | 2.37 |
Profitability
| EPS (TTM): | 6.57220 |
|---|---|
| Net Income (TTM): | $371.8M |
| Gross Margin: | $1.2B |
| Return on Equity: | 21.92% |
| Return on Assets: | 8.85% |
MAXIMUS, Inc. Earnings Forecast
Key MAXIMUS, Inc. Financial Ratios
-
The Gross Profit Margin over the past 30 years for MMS is 22.86%.
-
The Selling, General & Administrative Expenses for MMS have been equal to 13.13% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 23.69% of Operating Income.
-
The Net Earning history of MMS is 5.87% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 19 years.
MAXIMUS, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Professional Services |
| Sector: | Industrials |
| Current Symbol: | MMS |
| CUSIP: | 577933 |
| Website: | maximus.com |
Debt
| Debt-to-Equity Ratio: | 0.97 |
|---|---|
| Current Ratio: | 2.34 |
| Quick Ratio: | 2.2 |
Price-to-Earnings
| Trailing P/E Ratio: | 13.56 |
|---|---|
| Forward P/E Ratio: | 8.19 |
MMS Technical Analysis vs Fundamental Analysis
Sell
40
MAXIMUS, Inc. (MMS)
is a Sell
Is MAXIMUS, Inc. a Buy or a Sell?
-
MAXIMUS, Inc. stock is rated a SellThe current MAXIMUS, Inc. [MMS] share price is $74.69. The Score for MMS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.